Delivery of Pleckstrin‐Homology Domains Suppresses PI3K/Akt Signaling and Breast Cancer Metastasis
Advanced Science · 2026
DOI: 10.1002/advs.202518339 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Science, 2026. Verfasst von Matthew Eason und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry and Molecular Biology, University of Maryland School of Medicine, Baltimore, Maryland, USA. Hauptthemen laut MEDLINE: Breast Neoplasms, Proto-Oncogene Proteins c-akt, Phosphatidylinositol 3-Kinases, Pleckstrin Homology Domains. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 60 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIGMS NIH HHS, NCI NIH HHS, NIH/NIGMS.
Abstract (Originalsprache)
Current cancer therapies inhibit tumor growth but fail to target metastatic dissemination. Obscurin (720–870 kDa), a giant signaling protein localizing to the breast epithelial cell membrane, is a metastasis suppressor commonly lost in breast cancer. Obscurin loss upregulates the oncogenic PI3K/Akt axis. While restoring obscurin expression is crucial from a translational standpoint, it poses major challenges due to its immense size. Herein, we overcome this hurdle by delivering a mini‐obscurin—comprising the obscurin‐pleckstrin homology (PH) domain, which is ∼50‐times smaller than the full‐length protein—into aggressive breast cancer cells via adenovirus and lipid nanoparticles. Mechanistically, the obscurin‐PH‐domain interacts with the PI3K‐p85 regulatory subunit. Membrane‐targeted obscurin‐PH sequesters p85, suppressing PI3K/Akt activity. p85‐sequestration eliminates filopodia, hampering migration and adhesion to pre‐metastatic niche extracellular matrix substrates. This intervention further eradicates invadopodia and reduces matrix metalloproteinase expression, blocking invasion, dissemination, and metastasis. We recapitulate this phenotype using the structurally homologous kalirin and PLCγ1 PH‐domains and ultimately uncover a family of nine PH‐domains that may act as PI3K inhibitors, unified by the “ p 85 i nhibitory m etastasis s uppressor” (PIMS) motif, mediating this effect. This work engineers a first‐in‐class group of non‐chemical PI3K inhibitors, uniquely targeting the PI3K‐p85 subunit, galvanizing novel gene therapies for treating metastatic breast cancer.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biochemistry and Molecular Biology, University of Maryland School of Medicine, Baltimore, Maryland, USA.
- Marlene and Stewart Greenebaum Comprehensive Cancer Center, Baltimore, Maryland, USA.
- Department of Chemical and Biomolecular Engineering, The Johns Hopkins University, Baltimore, Maryland, USA.
- Institute For NanoBioTechnology, Johns Hopkins University, Baltimore, Maryland, USA.
- Department of Pharmacology and Physiology, University of Maryland School of Medicine, Baltimore, Maryland, USA.
- Department of Neurosurgery, University of Maryland School of Medicine, Baltimore, Maryland, USA.
ORCID-Profile: Aikaterini Kontrogianni-Konstantopoulos
Förderung
- NIGMS NIH HHS
- NCI NIH HHS
- NIH/NIGMS
- NIH/NCI
- National Science Foundation
- National Institute of General Medical Sciences
- National Cancer Institute
Zitieren
APA
Eason, M., Sen, A., Cho, S., Lee, S. J., Thompson, K., Mahmud, M. M., Dubey, P., Guardia, T., Kim, A., Martin, S., Wright, N., Konstantopoulos, K., & Kontrogianni-Konstantopoulos, A. (2026). Delivery of Pleckstrin‐Homology Domains Suppresses PI3K/Akt Signaling and Breast Cancer Metastasis. Advanced Science. https://doi.org/10.1002/advs.202518339
Vancouver
Eason M, Sen A, Cho S, Lee SJ, Thompson K, Mahmud MM, et al. Delivery of Pleckstrin‐Homology Domains Suppresses PI3K/Akt Signaling and Breast Cancer Metastasis. Advanced Science. 2026. doi:10.1002/advs.202518339
BibTeX
@article{Eason2026,
author = {Eason, Matthew and Sen, Anindya and Cho, Suhan and Lee, Se Jong and Thompson, Keyata and Mahmud, Md Musavvir and Dubey, Poornima and Guardia, Talia and Kim, Anthony and Martin, Stuart and Wright, Nathan and Konstantopoulos, Konstantinos and Kontrogianni-Konstantopoulos, Aikaterini},
title = {Delivery of Pleckstrin‐Homology Domains Suppresses PI3K/Akt Signaling and Breast Cancer Metastasis},
journal = {Advanced Science},
year = {2026},
doi = {10.1002/advs.202518339}
}
EUVIMED